OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
24/10/2025
Voltar para busca
Dado oficial do USPTO
MYXPRESSION
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MYXPRESSION
ST13
US500000079364822Classe
5, 10, 35, 42, 44
Pedido
79364822
Registro
7435487
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
25/10/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 35, 42, 44
Data de depósito
02/11/2022
Data de registro
09/07/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/07/2024
Última transação
25/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
FR
Examinador
MAHMOUDI,MARIAM AZIZ
Localização atual
FILE DESTROYED
Titulares e representantes
Titulares
SAS mYXpression
Representantes
Rebeccah Gan Muncy, Geissler, Olds & Lowe, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Chemical preparations for medical use for treating inflammatory disorders and autoimmune diseases; diagnostic preparations for medical or veterinary use; chemical reagents for medical or veterinary use; diagnostic biomarking reagents for medical use; diagnostic biomarker reagents for assisting in the selection of a therapeutic treatment for medical purposes * ; salivary swabs for diagnostic purposes for medical use; blood collection swabs for diagnostic purposes for medical use *
Classe 10
Diagnostic apparatus for medical usedevice for analyzing therapeutic efficacy and prescribing drug treatments; lancets for medical usescalpels ; salivary swabs for diagnostic purposes for medical use; blood collection swabs for diagnostic purposes for medical use
Classe 35
Compilation of information in computer databases; updating and maintenance of data in computer databases; systematization of information in computer databases
Classe 42
Chemical analysis; chemistry servicesresearch and development in the field of biochemistry; surveyingengineering surveying work; scientific laboratory services; research and development of new products for others in the field of health and medical diagnostics; chemical research; technical research in the field of medical diagnostics; biological research
Classe 44
Assistance with medical diagnosticsperforming prediction of patient response to therapeutic treatments; genomic data bank serviceshuman tissue and human cell bank services; genomic analysis for medical diagnostics; advice with respect to health; telemedicine services; therapeutic servicesassistance in analyzing therapeutic efficacy and prescribing drug treatments; medical diagnostic servicespredictive services in the field of inflammatory disorders and autoimmune diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/10/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/10/2025
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
10/07/2025
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
29/04/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/04/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
17/01/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
31/12/2024
FIMP
FINAL DISPOSITION PROCESSED
31/12/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/10/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
15/08/2024
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
13/08/2024
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
12/08/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/08/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/07/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/07/2024
GPNX
NOTIFICATION PROCESSED BY IB
22/05/2024
RINX
USPTO CORRECTION PROCESSED BY IB
12/05/2024
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
12/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/04/2024
PUBO
PUBLISHED FOR OPPOSITION
23/04/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/04/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/04/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/03/2024
CRSN
CORRECTION SENT TO IB
04/01/2024
CRCR
CORRECTION CREATED FOR IB
03/01/2024
RFNT
REFUSAL PROCESSED BY IB
11/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
14/09/2023
RFRR
REFUSAL PROCESSED BY MPU
14/09/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/08/2023
CNRT
NON-FINAL ACTION WRITTEN
22/08/2023
DOCK
ASSIGNED TO EXAMINER
17/08/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
17/04/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/04/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
17/04/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/04/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/04/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
17/04/2023
MAFR
APPLICATION FILING RECEIPT MAILED
21/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/03/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
16/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/03/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MYXPRESSION ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.